|Day's range||1.32 - 1.46|
|52-week range||1.20 - 2.67|
|PE ratio (TTM)||N/A|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|
WMGI reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wright Medical Group N.V. (WMGI) reported adjusted loss of 9 cents per share in the first quarter of 2017, wider than the Zacks Consensus Estimate of a loss of 8 cents.
A global medical device company with corporate headquarters in Memphis reported a net loss for the quarter but optimism and growth for the rest of the year. The net loss included the after-tax effects of $3 million of transition costs, an unrealized loss of $400,000 related to mark-to-market adjustments on derivatives, $11 million of non-cash interest expense related to its convertible notes, and a $6.2 million unrealized loss related to mark-to-market adjustments on contingent value rights (CVRs) issued in connection with its 2012 acquisition of BioMimetic Therapies. Wright Medical Group anticipates net sales for the year to be about $755 million, or an increase of about 9 to 11 percent.